David E. Johnson

David Johnson is currently the Managing Partner at Caligan Partners LP, a position held since 2017. They have served on the Board of Directors for AMAG Pharmaceuticals from 2019 to 2020 and are currently a board member at both Exelixis and Liquidia Corporation. Prior to their current role, David worked as a Managing Director at The Carlyle Group from 2010 to 2017 and as a Vice President at Morgan Stanley from 2004 to 2010. They earned both an AB and SM in Applied Mathematics from Harvard University between 2000 and 2004.